个股档案 |
|
|
财务比率->(600789)鲁抗医药
|
|
|
|
|
财务指标 |
鲁抗医药 |
同行业平均(70) |
市场平均(1463) |
财务结构 |
资产负债率 |
50.65% |
36.28% |
42.24% |
资本化比率 |
31.64% |
6.33% |
10.39% |
固定资产净值率 |
96.63% |
79.35% |
90.05% |
资本固定化比率 |
135.82% |
70.91% |
115.45% |
偿还能力 |
流动比率 |
1.22% |
2.59% |
1.91% |
速动比率 |
0.92% |
2.22% |
1.5% |
现金比率 |
0.3% |
1.48% |
0.86% |
资本周转比率 |
0.5% |
47.93% |
100.44% |
清算价值比率 |
196.6% |
345.15% |
301.05% |
利息支付能力(倍) |
4.13 |
59.75 |
40.22 |
经营能力 |
应收帐款周转率(次) |
2.76 |
4.75 |
30.55 |
存货周转率(次) |
2.57 |
3.3 |
34.25 |
流动资产周转率 |
0.92% |
0.96% |
1.17% |
总资产周转率 |
0.33% |
0.58% |
0.58% |
净资产增长率 |
2.77% |
96.47% |
149.4% |
获利能力 |
毛利率 |
24.29% |
41.27% |
28.22% |
营业利润率 |
10.04% |
13.17% |
9.09% |
利润率 |
9.14% |
11.92% |
11.92% |
净利润增长率 |
17.91% |
10.69% |
762.71% |
净资产收益率 |
6.07% |
7.35% |
7.48% |
总资产收益率 |
3.01% |
5.06% |
4.18% |
|
|
|